Open AccessP25: CARFILZOMIB‐BASED TREATMENTS COULD BE ADDED TO IMPEDE‐VTE SCORE TO BETTER PREDICT VENOUS THROMBOEMBOLIC RISK IN MM PATIENTS
Author(s) -
Morè S,
Manieri V M,
Corvatta L,
Morsia E,
Rupoli S,
Olivieri A,
Offidani M
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829672.61767.68
Subject(s) - lenalidomide , medicine , carfilzomib , multiple myeloma , venous thromboembolism , population , oncology , surgery , thrombosis , environmental health